Immunotherapy and cytokines

被引:9
|
作者
VanKampen, KR
机构
[1] Van Kampen Group, Inc., Ogden, UT
[2] Van Kampen Group, Inc., Ogden, UT 84405
关键词
D O I
10.1016/S1096-2867(97)80032-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Immunomodulation is now possible in veterinary medicine with the licensure of a number of biological products by the United States Department of Agriculture for veterinary use. These products activate primarily macrophages, induce the production of cytokines, and have various effects on the activity and proliferation of B and T lymphocytes. Those products most commonly used are inactivated whole bacteria of Propionibacterium acnes, cell wall fractions of nonpathogenic Mycobacterium spp, and the lysate derived from lysis of Staphylococcus aureus by a bacterial phage. All products have been licensed for use against specific diseases, but the literature includes studies for off-label usage. These immunomodulators are considered to be nonspecific stimulators of the immune system and may affect both humoral and cellular functions of immunity. Copyright © 1997 by W.B. Saunders Company.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 50 条
  • [21] The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy
    Xiaohu Zheng
    Yaqi Wu
    Jiacheng Bi
    Yingying Huang
    Ying Cheng
    Yangyang Li
    Yuwei Wu
    Guoshuai Cao
    Zhigang Tian
    Cellular & Molecular Immunology, 2022, 19 : 192 - 209
  • [22] The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy
    Zheng, Xiaohu
    Wu, Yaqi
    Bi, Jiacheng
    Huang, Yingying
    Cheng, Ying
    Li, Yangyang
    Wu, Yuwei
    Cao, Guoshuai
    Tian, Zhigang
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (02) : 192 - 209
  • [23] Particle-mediated delivery of cytokines for immunotherapy
    Christian, David A.
    Hunter, Christopher A.
    IMMUNOTHERAPY, 2012, 4 (04) : 425 - 441
  • [24] Combination immunotherapy with monoclonal antibodies and cytokines for neuroblastoma
    Handgretinger, R
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1995, 2 (06): : 495 - 501
  • [25] Immunotherapy of lymphoma by cytokines and allogeneic cell therapy
    Slavin, S
    Nagler, A
    Naparstek, E
    Varadi, G
    Ben-Yosef, R
    Aker, M
    Cividalli, G
    Ackerstein, A
    Samuel, S
    Or, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S382 - S382
  • [26] Current Development Status of Cytokines for Cancer Immunotherapy
    Song, Kyoung
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (01) : 13 - 24
  • [27] The role of cytokines in shaping the future of Cancer immunotherapy
    Safaei, Sahar
    Yari, Amirhossein
    Pourbagherian, Omid
    Maleki, Leili Aghebati
    CYTOKINE, 2025, 189
  • [28] Engineering cytokines for cancer immunotherapy: a systematic review
    Fu, Yong
    Tang, Renhong
    Zhao, Xiaofeng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] EFFECTS OF IMMUNOTHERAPY ON IGE-REGULATING CYTOKINES
    RASP, G
    SCHNEIDER, A
    HOCHSTRASSER, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 290 - 290
  • [30] Cells and cytokines in immunotherapy and gene therapy of cancer
    Pawelec, G
    Rees, RC
    Kiessling, R
    Madrigal, A
    Dodi, A
    Baxevanis, C
    Gambacorti-Passerini, C
    Masucci, G
    Zeuthen, J
    CRITICAL REVIEWS IN ONCOGENESIS, 1999, 10 (1-2): : 83 - 127